Skip To Content

ACD/Labs Blog

Daria Thorp
President and CEO, Daria Thorp, reflects on the past year and how the emerging technology of Generative AI and Machine Learning (ML) application in drug discovery and development has inspired companies to look for further industrial applications.

Daria Thorp
If you haven’t already heard, it’s our 25th year in business. This milestone has been a magnificent journey achieved by our team’s drive to help the scientific community solve research challenges and accelerate innovation. As regulatory agencies have placed increased pressure on our customers, partners, and collaborators, we’ve stood the test of time by providing software that supports processes and workflows to ensure safety, quality, and data integrity. Our motto this year is Connect—Align—Learn. We aim to connect more with our customers, align with their needs, and learn as much as possible over the next twelve months. As we mark this silver anniversary, I found it only fitting to share 25 achievements we’ve celebrated along the way.

Daria Thorp
As 2018 comes to a close and we approach a milestone year for ACD/Labs—2019 will be our 25th year in business—I reflect on the vigorous path of innovation ACD/Labs has taken in the last few years. For a business to remain relevant and vibrant, particularly in the science and technology sector, addressing the current needs of our customers, and most importantly anticipating those that lie ahead, is vital.